Letermovir for Cytomegalovirus Prophylaxis in High Risk Heart Transplant Recipients. Golob S, Batra J, DeFilippis EM, Uriel M, et al. Clin Transplant 2022 Sep 10:e14808. doi: 10.1111/ctr.14808.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Golob S, Batra J, DeFilippis EM, Uriel M, et al. Letermovir for Cytomegalovirus Prophylaxis in High Risk Heart Transplant Recipients. Clin Transplant 2022 Sep 10:e14808. doi: 10.1111/ctr.14808.
PMID: 36086937